Results

Total Results: 2,259 records

Showing results for "measured".
Users also searched for: quality measures

  1. effectivehealthcare.ahrq.gov/sites/default/files/pdf/patient-generated-health-data-protocol-chronic-conditions.pdf
    March 17, 2020 - How was adherence measured? f. What was the comparator? 3 g. … Which outcomes were measured? 2. … cost and effectiveness of interventions, such as cost per QALY, were included if effectiveness was measured … and effectiveness of interventions, such as cost per QALY, were included if effectiveness was measured
  2. effectivehealthcare.ahrq.gov/products/glaucoma-screening/research-protocol
    November 16, 2010 - The goal of treatment for open-angle glaucoma is to “achieve a stable range of measured intraocular pressures … Secondary outcome : We will also compare visual acuity outcomes (as measured by the Early Treatment Diabetic … Outcomes for Key Question 2: Mean total or relevant item/subscale scores of the participants as measured … calculate mean differences; standardized mean differences will be calculated if continuous outcomes are measured
  3. effectivehealthcare.ahrq.gov/products/glaucoma-treatment/research-protocol
    November 16, 2010 - Secondary outcome: We will also compare visual acuity outcomes (as measured by the Early Treatment Diabetic … Outcomes for Key Question 2: Mean total or relevant item/subscale scores of the participants as measured … with progression of visual field loss as defined by the Early Manifest Glaucoma Trial 10 and as measured … Standardized mean differences will be calculated if continuous outcomes are measured by using different
  4. effectivehealthcare.ahrq.gov/sites/default/files/pdf/glaucoma-screening_research-protocol.pdf
    November 16, 2010 - • The goal of treatment for open-angle glaucoma is to “achieve a stable range of measured intraocular … Secondary outcome: We will also compare visual acuity outcomes (as measured by the Early Treatment … Outcomes for Key Question 2: Mean total or relevant item/subscale scores of the participants as measured … calculate mean differences; standardized mean differences will be calculated if continuous outcomes are measured
  5. effectivehealthcare.ahrq.gov/sites/default/files/pdf/glaucoma-treatment_research-protocol.pdf
    November 16, 2010 - Secondary outcome: We will also compare visual acuity outcomes (as measured by the Early Treatment … Published Online: November 16, 2010 Mean total or relevant item/subscale scores of the participants as measured … participants with progression of visual field loss as defined by the Early Manifest Glaucoma Trial10 and as measured … Standardized mean differences will be calculated if continuous outcomes are measured by using different
  6. effectivehealthcare.ahrq.gov/products/ptsd-adult-treatment-update/research-2018
    May 17, 2018 - Our network meta-analysis (33 trials; N=4,817) of Clinician-Administered PTSD Scale (CAPS)-measured PTSD
  7. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0320_06-17-2009.pdf
    January 01, 2009 - Are the number of bone marrow biopsies and/or whole body scans decreased in NSMM when FLCs are measured
  8. effectivehealthcare.ahrq.gov/sites/default/files/pdf/osteoporosis-vibration-therapy_technical-brief.pdf
    January 01, 2020 - indications for the intervention, relevant patient population and subgroups of interest, outcomes measured … also measured other bone outcomes such as bone mineral content, fractures, and bone turnover markers … Studies that measured compliance found a wide range, raising questions about long-term adherence for … When should patient outcomes be measured (length of followup)? … Vibration outcomes I (continued) Author, Year Measured Compliance Comparators N for Comparator
  9. effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-march-2023-grand-rounds-slides.pdf
    January 01, 2023 - • Outcomes were defined widely and were measured using a variety of approaches. … telehealth 48 Study Design Considerations *Before/After: different groups/systems measured … before and after implementation RCT and other designs by setting † Pre/Post: same group measured before
  10. effectivehealthcare.ahrq.gov/sites/default/files/cer-225-substance-abuse-adolescents-comments.pdf
    May 21, 2020 - Comment Response American Psychological Association (APA) Methods Was inter-rater reliability measured
  11. effectivehealthcare.ahrq.gov/sites/default/files/pdf/study-design-framework_research.pdf
    March 01, 2012 - If a question cannot be answered because all existing studies only measured surrogate markers, additional … Baseline characteristics can be measured, but may not be balanced between the two groups. … There may be differences in both measured and unmeasured characteristics at baseline. … Controlled Before–After Study In a controlled before-after study, the outcome(s) of interest is measured … In all cases the investigator(s) controls the timing of the measurement and the variables being measured
  12. S131 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/s131.pdf
    October 01, 2007 - The ideal comparison group should comprise patients with identical distributions of measured and unmeasured … cardiac risks; nonusers as defined above may differ substantially from users of the index drug for both measured … Propensity scores estimate each patient’s proba- bility of treatment given all measured covariates. … would have been eligible to participate in the PROS- PER trial18 based on their baseline covariates as measured … 3 (propensity score trimming) and 5 (restriction to typical trial exclusion criteria) are based on measured
  13. effectivehealthcare.ahrq.gov/products/transparency-neuropathy/research-protocol
    September 06, 2016 - What would be the impact on the strength of evidence (including impact of knowledge of outcomes measured … What would be the impact on the strength of evidence (including impact of knowledge of outcomes measured
  14. effectivehealthcare.ahrq.gov/products/back-pain-treatment/clinician
    November 15, 2016 - Outcomes were mostly measured at short-term (up to 6 months) followup. … Effects on function were generally smaller than effects on pain; additionally, fewer studies measured
  15. effectivehealthcare.ahrq.gov/sites/default/files/pdf/back-pain-treatment_clinician.pdf
    November 01, 2016 - . �� Outcomes were mostly measured at short-term (up to 6 months) followup. �� Effects on function … were generally smaller than effects on pain; additionally, fewer studies measured function only.
  16. effectivehealthcare.ahrq.gov/sites/default/files/study-design-considerations-chapter-2.pptx
    January 01, 2013 - treatment groups compared must have the same underlying risk for outcome within subgroups definable by measured … treatment groups compared have the same underlying risk for the outcome within subgroups definable by measured … Prior exposure history of cases used as the control Removes confounding effect of measured and unmeasured … While confounding by measured covariates can usually be addressed by standard epidemiologic methods,
  17. effectivehealthcare.ahrq.gov/products/disparities-quality-improvement/research-protocol
    February 22, 2012 - services, or suppliers for the purpose of increasing the likelihood of optimal clinical quality of care measured … the intervention to the individual patients or the health care system will be captured if they are measured … disparities in health care between certain groups of patients are numerous and well described but not clearly measured … services, or suppliers for the purpose of increasing the likelihood of optimal clinical quality of care, measured
  18. effectivehealthcare.ahrq.gov/sites/default/files/pdf/colon-cancer-gene-profiling_technical-brief.pdf
    December 01, 2012 - for example, current indications, relevant patient populations and subgroups of interest, outcomes measured … Thus, MSI-status needs to be measured and/or taken into consideration in the analysis. … This can be measured through prospective studies. … • What aspects of analytic validity were measured (e.g., accuracy, reproducibility)? … o For response to adjuvant chemotherapy, how was it measured?
  19. effectivehealthcare.ahrq.gov/sites/default/files/related_files/mrsa-screening-2010_executive.pdf
    January 01, 2010 - decolonize) when compared with no screening on: • Intermediate outcomes such as MRSA transmission (as measured … patient populations (targeted screening) on: • Intermediate outcomes such as MRSA transmission (as measured … decolonize) when compared with no screening on: • Intermediate outcomes such as MRSA transmission as measured … such as patients admitted to the ICU) on: • Intermediate outcomes such as MRSA transmission (as measured … As a result, the measured effect of the screening strategy may have been influenced by the application
  20. S108 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/s108.pdf
    October 01, 2007 - , particularly in comparison to propensity scores, another method for re- moving confounding due to measured … In practice, severity of illness is not likely to be measured at intervals more frequently than 4 times … for confounding control, IPW illustrates the key principle that making exposure indepen- dent of the measured … covariate history removes confounding due to measured variables. … Measured indicators of severity of illness do demonstrate substantial day-to-day variability, comparable

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: